Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Maged Shenouda

CFO at Relmada Therapeutics, Inc. (RLMD)

Purchase track record

Strong record. Based on 2 purchases with a full 90 days of price history.

93
Avg. 90-day return+38.6%
vs. S&P 500+37.8%
Beat the market100%
Paper profit on buys+$420K
Total bought / sold$2.0M / $0

Reported trades

Filed Stock Type Shares Price Value Since
Sep 11SEC RLMDRelmada Therapeutics, Inc. Buy 120,200920,200 held (+15%) $4.20 $505K -19.3%
Sep 11SEC RLMDRelmada Therapeutics, Inc. Buy 79,8001,000,000 held (+9%) $4.25 $339K -20.2%
Dec 16SEC RLMDRelmada Therapeutics, Inc. Buy 11,665800,000 held (+1%) $4.12 $48K -17.7%
Nov 6SEC RLMDRelmada Therapeutics, Inc. Buy 500,000788,335 held (+173%) $2.20 $1.1M +54.1%
  • Buy

    CFO Maged Shenouda bought $1.1M of RLMD at $2.20 — first open-market purchase in our records; raises the stake by 173%.